Kosmos Energy Ltd - Director/PDMR Shareholding

02/05/24 07:00 GMT

RNS Number : 9417B

Kosmos Energy Limited

05 February 2024

Kosmos Energy Ltd (the "Company")
PDMR Shareholding

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES

05 February 2024

The following Persons Discharging Managerial Responsibilities ("PDMRs") have had changes in their shareholdings of Common Stock in the Company:

PDMR	Date of transaction	No. of shares vested	No. of shares granted	No. of shares sold or withheld
Christopher J. Ball	31 January 2024	493,000	99,525	0
Christopher J. Ball	1 February 2024	0	0	114,423
Christopher J. Ball	2 February 2024	0	0	118,144
Jason E. Doughty	31 January 2024	344,647	0	0
Jason E. Doughty	1 February 2024	0	0	66,616
Jason E. Doughty	2 February 2024	0	0	69,025
Ronald W. Glass	31 January 2024	85,000	50,000	0
Ronald W. Glass	1 February 2024	0	0	17,525
Ronald W. Glass	2 February 2024	0	0	18,115
Andrew G. Inglis	31 January 2024	837,500	270,600	0
Andrew G. Inglis	1 February 2024	0	0	166,524
Andrew G. Inglis	2 February 2024	0	0	171,941
Neal D. Shah	31 January 2024	423,000	148,500	0
Neal D. Shah	1 February 2024	0	0	84,672
Neal D. Shah	2 February 2024	0	0	87,655

The Notification of Dealing Form for each PDMR, which provides full details of the transactions outlined above, can be found below.

This notification is made in accordance with Article 19 of the EU Market Abuse Regulation.

Josh R. Marion

Assistant Secretary

CONTACT:

Investor Relations

Jamie Buckland
+44 203 954 2831
jbuckland@kosmosenergy.com

Media Relations

Thomas Golembeski
+1-214-445-9674
tgolembeski@kosmosenergy.com

1.	Details of PDMR / person closely associated with them ("PCA")
a)	Name	Christopher J. Ball
b)	Position / status	SVP and Chief Commercial Officer
c)	Initial notification / amendment	Initial notification
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Common Stock, par value $0.01 per share
b)	Nature of the transactions	(1) 493,000 shares issued on settlement of restricted share units granted to the reporting person on 31 January 2021 under the Company's Long Term Incentive Plan (the "Plan") based on the target level of achievement of the applicable performance condition. (2) 99,525 restricted share units granted under the Plan which are scheduled to vest with respect to one-third of the total number of shares on January 31 of each of 2025, 2026 and 2027, subject to the terms of the Plan and the applicable award agreement issued thereunder.
Shares Granted or Vested
c)	Currency	USD
	Price	6.06
	Volume	592,525
	Total	3,590,701.50
Shares sold or withheld
d)	Currency	USD
	Price	0
	Volume	0
	Total	0
e)	Aggregated information
	Price	6.06
	Volume	592,525
	Total	3,590,701.50
f)	Date of the transactions	31 January 2024
g)	Place of the transaction	NYSE
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Common Stock, par value $0.01 per share
b)	Nature of the transactions	114,423 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.
Shares Granted or Vested
c)	Currency	USD
	Price	0
	Volume	0
	Total	0
Shares sold or withheld
d)	Currency	USD
	Price	6.0287
	Volume	114,423
	Total	689,821.94
e)	Aggregated information
	Price	6.0287
	Volume	114,423
	Total	689,821.94
f)	Date of the transactions	1 February 2024
g)	Place of the transaction	NYSE
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Common Stock, par value $0.01 per share
b)	Nature of the transactions	118,144 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.
Shares Granted or Vested
c)	Currency	USD
	Price	0
	Volume	0
	Total	0
Shares sold or withheld
d)	Currency	USD
	Price	5.8388
	Volume	118,144
	Total	689,819.19
e)	Aggregated information
	Price	5.8388
	Volume	118,144
	Total	689,819.19
f)	Date of the transactions	2 February 2024
g)	Place of the transaction	NYSE

1.	Details of PDMR / person closely associated with them ("PCA")
a)	Name	Jason E. Doughty
b)	Position / status	SVP and General Counsel
c)	Initial notification / amendment	Initial notification
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Common Stock, par value $0.01 per share
b)	Nature of the transactions	344,647 shares issued on settlement of restricted share units granted to the reporting person on 31 January 2021 under the Company's Long Term Incentive Plan (the "Plan") based on the target level of achievement of the applicable performance condition.
Shares Granted or Vested
c)	Currency	USD
	Price	6.06
	Volume	344,647
	Total	2,088,560.82
Shares sold or withheld
d)	Currency	USD
	Price	0
	Volume	0
	Total	0
e)	Aggregated information
	Price	6.06
	Volume	344,647
	Total	2,088,560.82
f)	Date of the transactions	31 January 2024
g)	Place of the transaction	NYSE
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Common Stock, par value $0.01 per share
b)	Nature of the transactions	66,616 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.
Shares Granted or Vested
c)	Currency	USD
	Price	0
	Volume	0
	Total	0
Shares sold or withheld
d)	Currency	USD
	Price	6.0287
	Volume	66,616
	Total	401,607.88
e)	Aggregated information
	Price	6.0287
	Volume	66,616
	Total	401,607.88
f)	Date of the transactions	1 February 2024
g)	Place of the transaction	NYSE
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Common Stock, par value $0.01 per share
b)	Nature of the transactions	69,025 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.
Shares Granted or Vested
c)	Currency	USD
	Price	0
	Volume	0
	Total	0
Shares sold or withheld
d)	Currency	USD
	Price	5.8388
	Volume	69,025
	Total	403,023.17
e)	Aggregated information
	Price	5.8388
	Volume	69,025
	Total	403,023.17
f)	Date of the transactions	2 February 2024
g)	Place of the transaction	NYSE

1.	Details of PDMR / person closely associated with them ("PCA")
a)	Name	Ronald W. Glass
b)	Position / status	Vice President and Chief Accounting Officer
c)	Initial notification / amendment	Initial notification
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Common Stock, par value $0.01 per share
b)	Nature of the transactions	(1) 85,000 shares issued on settlement of restricted share units granted to the reporting person on 31 January 2021 under the Company's Long Term Incentive Plan (the "Plan") based on the target level of achievement of the applicable performance condition. (2) 50,000 restricted share units granted under the Plan which are scheduled to vest with respect to one-third of the total number of shares on January 31 of each of 2025, 2026 and 2027, subject to the terms of the Plan and the applicable award agreement issued thereunder.
Shares Granted or Vested
c)	Currency	USD
	Price	6.06
	Volume	135,000
	Total	818,100
Shares sold or withheld
d)	Currency	USD
	Price	0
	Volume	0
	Total	0
e)	Aggregated information
	Price	6.06
	Volume	135,000
	Total	818,100
f)	Date of the transactions	31 January 2024
g)	Place of the transaction	NYSE
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Common Stock, par value $0.01 per share
b)	Nature of the transactions	17,525 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.
Shares Granted or Vested
c)	Currency	USD
	Price	0
	Volume	0
	Total	0
Shares sold or withheld
d)	Currency	USD
	Price	6.0287
	Volume	17,525
	Total	105,652.97
e)	Aggregated information
	Price	6.0287
	Volume	17,525
	Total	105,652.97
f)	Date of the transactions	1 February 2024
g)	Place of the transaction	NYSE
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Common Stock, par value $0.01 per share
b)	Nature of the transactions	18,115 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.
Shares Granted or Vested
c)	Currency	USD
	Price	0
	Volume	0
	Total	0
Shares sold or withheld
d)	Currency	USD
	Price	5.8388
	Volume	18,115
	Total	105,769.86
e)	Aggregated information
	Price	5.8388
	Volume	18,115
	Total	105,769.86
f)	Date of the transactions	2 February 2024
g)	Place of the transaction	NYSE

1.	Details of PDMR / person closely associated with them ("PCA")
a)	Name	Andrew G. Inglis
b)	Position / status	Chairman and Chief Executive Officer
c)	Initial notification / amendment	Initial notification
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Common Stock, par value $0.01 per share
b)	Nature of the transactions	(1) 837,500 shares issued on settlement of restricted share units granted to the reporting person on 31 January 2021 under the Company's Long Term Incentive Plan (the "Plan") based on the target level of achievement of the applicable performance condition. (2) 270,600 restricted share units granted under the Plan which are scheduled to vest with respect to one-third of the total number of shares on January 31 of each of 2025, 2026 and 2027, subject to the terms of the Plan and the applicable award agreement issued thereunder.
Shares Granted or Vested
c)	Currency	USD
	Price	6.06
	Volume	1,108,100
	Total	6,715,086
Shares sold or withheld
d)	Currency	USD
	Price	0
	Volume	0
	Total	0
e)	Aggregated information
	Price	6.06
	Volume	1,108,100
	Total	6,715,086
f)	Date of the transactions	31 January 2024
g)	Place of the transaction	NYSE
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Common Stock, par value $0.01 per share
b)	Nature of the transactions	166,524 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.
Shares Granted or Vested
c)	Currency	USD
	Price	0
	Volume	0
	Total	0
Shares sold or withheld
d)	Currency	USD
	Price	6.0287
	Volume	166,524
	Total	1,003,923.24
e)	Aggregated information
	Price	6.0287
	Volume	166,524
	Total	1,003,923.24
f)	Date of the transactions	1 February 2024
g)	Place of the transaction	NYSE
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Common Stock, par value $0.01 per share
b)	Nature of the transactions	171,941 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.
Shares Granted or Vested
c)	Currency	USD
	Price	0
	Volume	0
	Total	0
Shares sold or withheld
d)	Currency	USD
	Price	5.8388
	Volume	171,941
	Total	1,003,929.11
e)	Aggregated information
	Price	5.8388
	Volume	171,941
	Total	1,003,929.11
f)	Date of the transactions	2 February 2024
g)	Place of the transaction	NYSE

1.	Details of PDMR / person closely associated with them ("PCA")
a)	Name	Neal D. Shah
b)	Position / status	Senior Vice President and Chief Financial Officer
c)	Initial notification / amendment	Initial notification
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Common Stock, par value $0.01 per share
b)	Nature of the transactions	(1) 423,000 shares issued on settlement of restricted share units granted to the reporting person on 31 January 2021 under the Company's Long Term Incentive Plan (the "Plan") based on the target level of achievement of the applicable performance condition. (2) 148,500 restricted share units granted under the Plan which are scheduled to vest with respect to one-third of the total number of shares on January 31 of each of 2025, 2026 and 2027, subject to the terms of the Plan and the applicable award agreement issued thereunder.
Shares Granted or Vested
c)	Currency	USD
	Price	6.06
	Volume	571,500
	Total	3,463,290
Shares sold or withheld
d)	Currency	USD
	Price	0
	Volume	0
	Total	0
e)	Aggregated information
	Price	6.06
	Volume	571,500
	Total	3,463,290
f)	Date of the transactions	31 January 2024
g)	Place of the transaction	NYSE
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Common Stock, par value $0.01 per share
b)	Nature of the transactions	84,672 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.
Shares Granted or Vested
c)	Currency	USD
	Price	0
	Volume	0
	Total	0
Shares sold or withheld
d)	Currency	USD
	Price	6.0287
	Volume	84,672
	Total	510,462.09
e)	Aggregated information
	Price	6.0287
	Volume	84,672
	Total	510,462.09
f)	Date of the transactions	1 February 2024
g)	Place of the transaction	NYSE
2.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument	Common Stock, par value $0.01 per share
b)	Nature of the transactions	87,655 shares sold to satisfy the tax withholding requirement arising from the vesting of restricted shares granted to the reporting person under the Plan.
Shares Granted or Vested
c)	Currency	USD
	Price	0
	Volume	0
	Total	0
Shares sold or withheld
d)	Currency	USD
	Price	5.8388
	Volume	87,655
	Total	511,800.01
e)	Aggregated information
	Price	5.8388
	Volume	87,655
	Total	511,800.01
f)	Date of the transactions	2 February 2024
g)	Place of the transaction	NYSE

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHSSEFILELSELE

Investors

News Release Details